Dhingra Kapil
Insider CIK 1456849 · FPRX Director · BDTX Director · REPL Director · LVTX Director · CRGX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | A Award deriv | 2026-06-26 | 2026-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2026-04-01 | 2026-04-07 | 44,500 | — | $0 | 44,500 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2025-12-09 | 2025-12-11 | 3,169 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2025-12-09 | 2025-12-11 | 3,169 | $1.75 | $5.5K | 3,169 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2025-12-09 | 2025-12-11 | 3,169 | $10.40 | $33.0K | 0 | SEC↗ |
| LVTX LAVA Therapeutics NV | D To issuer deriv | 2025-11-13 | 2025-11-17 | 33,390 | — | $0 | 0 | SEC↗ |
| LVTX LAVA Therapeutics NV | D To issuer | 2025-11-13 | 2025-11-17 | 30,000 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2025-06-12 | 2025-06-12 | 30,550 | — | $0 | 30,550 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| LVTX LAVA Therapeutics NV | A Award deriv | 2025-02-13 | 2025-02-18 | 33,390 | — | $0 | 33,390 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2024-06-06 | 2024-06-06 | 30,550 | — | $0 | 30,550 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 11,871 | — | $0 | 11,871 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2024-04-15 | 2024-04-17 | 49,265 | — | $0 | 49,265 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2023-05-16 | 2023-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2023-04-01 | 2023-04-04 | 25,200 | — | $0 | 25,200 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2022-06-10 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 16,500 | — | $0 | 16,500 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 15,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 20,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 25,000 | — | $0 | 0 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2021-04-01 | 2021-04-05 | 16,500 | — | $0 | 16,500 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-01-19 | 2021-01-22 | 29,842 | — | $0 | 29,842 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise deriv | 2020-12-07 | 2020-12-09 | 40,000 | — | $0 | 3,169 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-12-07 | 2020-12-09 | 13,523 | $46.22 | $625.0K | 1,802 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-12-07 | 2020-12-09 | 1,802 | $47.04 | $84.8K | 0 | SEC↗ |
| REPL Replimune Group, Inc. | S Sale | 2020-12-07 | 2020-12-09 | 24,675 | $45.09 | $1.11M | 15,325 | SEC↗ |
| REPL Replimune Group, Inc. | M Exercise | 2020-12-07 | 2020-12-09 | 40,000 | $1.75 | $70.0K | 40,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-05-14 | 2020-05-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2020-04-01 | 2020-04-02 | 16,500 | — | $0 | 16,500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2019-04-01 | 2019-04-03 | 13,500 | — | $0 | 13,500 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2018-07-24 | 2018-07-26 | 13,500 | — | $0 | 13,500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-05-10 | 2018-05-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-05-10 | 2017-05-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-05-19 | 2016-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-12-02 | 2015-12-03 | 25,000 | — | $0 | 25,000 | SEC↗ |